Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Pioglitazone hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pioglitazone 30mg tablets
0601023B0AAABAB
|
Pioglitazone hydrochloride | Pioglitazone hydrochloride | Endocrine System | 64,569 |
|
Pioglitazone 45mg tablets
0601023B0AAACAC
|
Pioglitazone hydrochloride | Pioglitazone hydrochloride | Endocrine System | 50,341 |
|
Pioglitazone 15mg tablets
0601023B0AAAAAA
|
Pioglitazone hydrochloride | Pioglitazone hydrochloride | Endocrine System | 46,336 |
|
Pioglitazone 15mg/5ml oral suspension
0601023B0AAAEAE
|
Pioglitazone hydrochloride | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Pioglitazone 30mg/5ml oral suspension
0601023B0AAADAD
|
Pioglitazone hydrochloride | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Pioglitazone 45mg/5ml oral suspension
0601023B0AAAFAF
|
Pioglitazone hydrochloride | Pioglitazone hydrochloride | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.